AtaiBeckley enters into new ATM equity offering agreement with Jefferies

AtaiBeckley Inc.

ATM allows AtaiBeckley to sell common stock via Jefferies as sales agent, replacing prior 2022 agreement.
Jefferies receives up to 3.0% commission on gross proceeds; no obligation to sell shares.
Proceeds to advance clinical development of product candidates and for working capital.
Sales will be made under effective S-3 registration statement filed March 9, 2026.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AtaiBeckley Inc. entered into Open Market Sale Agreement with Jefferies LLC (effective 2026-03-06).

Action: entry
Agreement: atm program
Counterparty: Jefferies LLC
Effective: 2026-03-06

Exact text from the filing

On March 6, 2026, AtaiBeckley Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC (“Jefferies”), pursuant to which the Company may issue and sell its common stock, par value $0.01 per share (the “Common Stock”), from time to time through an “at the market” equity offering program

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AtaiBeckley Inc. terminated Open Market Sale Agreement with Jefferies LLC (effective 2026-03-06).

Action: termination
Agreement: atm program
Counterparty: Jefferies LLC
Effective: 2026-03-06

Exact text from the filing

Also on March 6, 2026, the Company and Jefferies terminated the Open Market Sale Agreement SM dated as of November 10, 2022, by and between the Company and Jefferies.

View on SEC.gov

Browse all material agreements →

AtaiBeckley Inc. filing history →

Source: SEC EDGAR

accession 0001140361-26-008354

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.